BioShares Biotechnology Semi Deviation

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 30.75  0.51  1.63%

The Macroaxis Technical Indicators lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh
BioShares Biotechnology Clinical Trials has current Semi Deviation of 1.14. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.
BioShares Biotechnology 
Semi Deviation 
=  
SQRT(SV) 
 = 
1.14
SQRT =   Square root notation
SV =   BioShares Biotechnology semi variance of returns over selected period

Semi Deviation Comparison

BioShares Biotechnology Clinical Trials is rated below average in semi deviation as compared to similar ETFs. It is currently under evaluation in maximum drawdown as compared to similar ETFs reporting about  5.84  of Maximum Drawdown per Semi Deviation. The ratio of Maximum Drawdown to Semi Deviation for BioShares Biotechnology Clinical Trials is roughly  5.84 
Semideviation is the square root of semi variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare BioShares Biotechnology to competition
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. more
NameBioShares Biotechnology Clinical Trials
Macroaxis Advice
InstrumentUSA Etf ETF Directory
RegionNorth America
Investment IssuerBioShares
ExchangeNASDAQ General Markets
CurrencyUSD - US Dollar
IssuerBioShares
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management33.66 Million
Average Trading Valume17,594
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents86.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79